8-K
Current Report
Vistagen Therapeutics, Inc. Filed Acc 0001628280-26-019455
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading vtgn-20260317.htm…